विवरण
Subgroup analyses explore heterogeneity in curcumin efficacy for ulcerative colitis based on disease severity, curcumin dosage, and treatment duration. Results suggest dose-dependent benefits.
Figure 5
Forest PlotSource Paper
The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.Cite This Figure
![Figure 5: Subgroup analyses explore heterogeneity in curcumin efficacy for ulcerative colitis based on disease severity, curcumin dosage, and treatment duration. Results suggest dose-dependent benefits.]() > Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." *Nutrients*, 2020. PMID: [32751776](https://pubmed.ncbi.nlm.nih.gov/32751776/)
<figure> <img src="" alt="Subgroup analyses explore heterogeneity in curcumin efficacy for ulcerative colitis based on disease severity, curcumin dosage, and treatment duration. Results suggest dose-dependent benefits." /> <figcaption>Figure 5. Subgroup analyses explore heterogeneity in curcumin efficacy for ulcerative colitis based on disease severity, curcumin dosage, and treatment duration. Results suggest dose-dependent benefits.<br> Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751776/">32751776</a></figcaption> </figure>